Johnson & Johnson has received 510(k) clearance for a plating system for foot and ankle procedures.
The Food and Drug Administration cleared the system, TriLEAP, after concluding it is substantially equivalent to a device that Synthes, now part of J&J, brought to market in 2010. J&J is targeting elective and trauma procedures, including the “fast growing” bunion market. The 510(k) clearance comes shortly after Stryker introduced a minimally invasive system for treating bunions.